Plain-English translation of NCT04262830 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking at how certain chemotherapy drugs used to treat childhood cancer—particularly anthracycline chemotherapies like doxorubicin—can affect the heart over time. Researchers will use advanced heart imaging (cardiac MRI) to detect early signs of heart damage in young people who received these treatments, before serious heart problems develop.
Children who receive anthracycline chemotherapy have a higher risk of heart failure and heart disease as they grow up, but doctors currently don't have good ways to identify who will develop problems early on. This study aims to find better imaging markers that can help predict and prevent these complications.
You likely qualify if…
You likely don't qualify if…
You will have a cardiac MRI scan and other heart tests at the start of the study, and then again 3 or more years later. The MRI is a painless imaging test that takes pictures of your heart to look for any changes. Between these two visits, researchers will monitor how your heart is doing by reviewing your medical records and may ask you questions about your health.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
United States